Skip to main navigation Skip to search Skip to main content

Mortality rates of patients treated with Drotrecogin alfa for severe Sepsis based on PROWESS eligibility

Research output: Contribution to conferencePoster

Original languageAmerican English
StatePublished - Jan 1 2007

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this